The current state of myeloma therapy, plus the novel agents that may be next in line for FDA approval.Guest: Adriana Rossi, MD, Associate Director of the Myeloma Center at Weill Cornell Medicine and NewYork-Presbyterian Hospital.Host: John Leonard, MD, world-renowned hematologist and medical oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital.
